EMAIL THIS PAGE TO A FRIEND

Blood

Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.


PMID 23287624

Abstract

High-dose cytarabine applied during remission induction or as consolidation after attainment of a complete remission has become an established element in the treatment of adults with acute myeloid leukemia. Recent evidence has challenged the need for these exceptionally high-dose levels of cytarabine. In this review, we present a reappraisal of the usefulness of high-dose cytarabine for acute myeloid leukemia treatment.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C1768
Cytosine β-D-arabinofuranoside, crystalline, ≥90% (HPLC)
C9H13N3O5